Jump Trading’s Seres Therapeutics MCRB Stock Holding History

Jump Trading’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-731	Closed	-$100K	–	486
2019 Q1	$100K	Buy	+731	New	+$89.1K	0.03%	491

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Jump Trading's MCRB Position: Q2 2019 in Review

Jump Trading sold out of Seres Therapeutics (MCRB) in Q2 2019, closing a stake of 731 shares — an estimated $100K sold.

Jump Trading first reported a position in MCRB in Q1 2019 and held it in 1 quarter. The position peaked at $100K in Q1 2019. 91 funds tracked by Wall St. Rank hold MCRB as of Q2 2019.

Jump Trading reported no remaining Seres Therapeutics position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 731 Seres Therapeutics shares in Q2 2019, an estimated $100K.
Jump Trading first reported a position in Seres Therapeutics in Q1 2019 and held it in 1 quarter.
Jump Trading's Seres Therapeutics position peaked at $100K in Q1 2019.
91 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.